- Dec 08, 2020
- Business Update
6618.HK: JD Health to Improve Consumer Service Through Omnichannel Solution
by Hui Zhang & Ling Cao
JD Health will expand cooperation with offline hospitals and medical institutions, and continue increasing investment into supply chain to improve consumer services through omnichannel solutions. Lijun Xin, CEO of JD Health, elaborated on these plans during an press conference in Beijing after JD Health was listed on the Hong Kong Stock Exchange (HKEX) on Dec. 8.
“We saw investors are optimistic about China’s healthcare industry,” Xin said. “The biggest challenges we face are how to let more people know and experience our service, and how to combine offline medical institutions and hospitals with online medical resources.”
JD Health oversees retail and wholesale businesses covering pharmaceuticals, medical devices, and other healthcare products, both online and offline. The omnichannel solution is aimed at fulfilling consumers’ increasing healthcare consumption needs anytime and anywhere.
In addition to bringing high-quality and convenient health services to consumers, JD Health is also committed to facilitating the digitalization of its offline partners.
“Most offline pharmacies have not realized digitalization, and JD Health can leverage its capabilities to help them go digital,” Xin said. “At the same time, JD Health can promote online and offline integration and provide a comprehensive service including retail, healthcare management and supply chain.”
Leveraging its technology for small stores and supply chain advantages, JD has already partnered with more than 40 brands of offline pharmacy across China to provide data-driven recommendations about which products to stock, and help them better understand information about customer preferences.
JD Health listed on Hong Kong Stock Exchange (HKEX) on Dec. 8 with the ticker 6618.HK, and is set at a price of HK $70.58 per share.